Early cancer drug trial halted after testing in 17 patients
NCT ID NCT06625515
Summary
This early-stage study tested a new oral medication called ATX-559 in people with advanced solid tumors that had spread or returned after standard treatments. The main goals were to find a safe dose and see how the drug behaves in the body. The trial was terminated after enrolling 17 participants and did not proceed to later phases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
NEXT Oncology
San Antonio, Texas, 78229, United States
-
SCRI Oncology Partners
Nashville, Tennessee, 37203, United States
-
Stephenson Cancer Center at OU Medicine
Oklahoma City, Oklahoma, 73104, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Colorado Cancer Center - Anschutz Medical Campus,
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.